Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Immigrant and Minority Health
Published in: Journal of Immigrant and Minority Health 5/2014

01-10-2014 | Original Paper

High Prevalence of Cardiometabolic Risk Factors in Hispanic Adolescents: Correlations with Adipocytokines and Markers of Inflammation

Authors: Cynthia M. Pérez, Ana P. Ortiz, Enrique Fuentes-Mattei, Guermarie Velázquez-Torres, Damarys Santiago, Katya Giovannetti, Raúl Bernabe, Mong-Hong Lee, Sai-Ching J. Yeung

Published in: Journal of Immigrant and Minority Health | Issue 5/2014

Login to get access

Abstract

This study assessed the association of cardiometabolic risk factors with systemic inflammation, insulin resistance, and adypocytokines in a Hispanic adolescent subgroup. A clinic-based sample of 101 Puerto Rican adolescents, 48 of whom were overweight or obese based on body mass index percentiles for age and sex, was recruited during 2010. Data were collected through interviews, blood pressure and anthropometric measurements, and blood drawing. Overall prevalence of the metabolic syndrome was 16.8 % and increased to 37.5 % among overweight/obese youth. The overweight/obese group exhibited significantly (p < 0.05) higher values for abdominal obesity measures, systolic blood pressure, triglycerides, insulin resistance, C peptide, high-sensitivity C reactive protein, fibrinogen, leptin, and IL-6 and lower levels of high density lipoprotein cholesterol, adiponectin, and IGF-1. Total adiponectin significantly correlated with most cardiovascular risk factors independent of sex, Tanner stage, and adiposity. Altered cardiometabolic and adipocytokine profiles were present in this Hispanic subgroup, reinforcing the need to strengthen strategies addressing childhood obesity.
Literature
1.
Barlow SE, Expert Committee. Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics. 2007;120(4):S164–92.PubMedCrossRef
2.
Masi S, Charakida M, Wang G, et al. Hope for the future: early recognition of increased cardiovascular risk in children and how to deal with it. Eur J Cardiovasc Prev Rehabil. 2009;16(2):S61–4.PubMedCrossRef
3.
Ogden CL, Carroll MD, Curtin LR, et al. Prevalence of obesity in body mass index among US children and adolescents, 1999–2010. JAMA. 2012;307(5):483–90.PubMedCrossRef
4.
Wiegand S, Maikowski U, Blankenstein O, et al. Type 2 diabetes and impaired glucose tolerance in European children and adolescents with obesity—a problem that is no longer restricted to minority groups. Eur J Endocrinol. 2004;151(2):199–206.PubMedCrossRef
5.
Li C, Ford ES, Zhao G, et al. Prevalence of pre-diabetes and its association with clustering of cardiometabolic risk factors and hyperinsulinemia among US adolescents: National Health and Nutrition Examination Survey 2005–2006. Diabetes Care. 2009;32:342–7.PubMedCentralPubMedCrossRef
6.
Johnson WD, Kroon JM, Greenway FL, et al. Prevalence of risk factors for metabolic syndrome in adolescents: National Health and Nutrition Examination Survey (NHANES), 2001–2006. Arch Pediatr Adolesc Med. 2009;163:371–7.PubMedCrossRef
7.
Cruz ML, Weigensberg MJ, Huang TT, et al. The metabolic syndrome in overweight Hispanic youth and the role of insulin sensitivity. J Clin Endocrinol Metab. 2004;89:108–13.PubMedCrossRef
8.
Goran MI, Bergman RN, Avila Q, et al. Impaired glucose tolerance and reduced beta-cell function in overweight Latino children with a positive family history for type 2 diabetes. J Clin Endocrinol Metab. 2004;89:207–12.PubMedCrossRef
9.
Goran MI, Bergman RN, Cruz ML, et al. Insulin resistance and associated compensatory responses in African-American and Hispanic children. Diabetes Care. 2002;25:2184–90.PubMedCrossRef
10.
Weigensberg MJ, Ball GD, Shaibi GQ, et al. Decreased beta-cell function in overweight Latino children with impaired fasting glucose. Diabetes Care. 2005;28:2519–24.PubMedCrossRef
11.
Cruz M, García-Macedo R, García-Valerio Y, et al. Low adiponectin levels predict type 2 diabetes in Mexican children. Diabetes Care. 2004;27:1451–3.PubMedCrossRef
12.
Winer JC, Zern TL, Taksali SE, et al. Adiponectin in childhood and adolescent obesity and its association with inflammatory markers and components of the metabolic syndrome. J Clin Endocrinol Metab. 2006;91:4415–23.PubMedCrossRef
13.
Butte NF, Comuzzie AG, Cai G, et al. Genetic and environmental factors influencing fasting serum adiponectin in Hispanic children. J Clin Endocrinol Metab. 2005;90:4170–6.PubMedCrossRef
14.
Shaibi GQ, Cruz ML, Weigensberg MJ, et al. Adiponectin independently predicts metabolic syndrome in overweight Latino youth. J Clin Endocrinol Metab. 2007;92:1809–13.PubMedCrossRef
15.
Gilardini L, McTernan PG, Girola A, et al. Adiponectin is a candidate marker of metabolic syndrome in obese children and adolescents. Atherosclerosis. 2006;189:401–7.PubMedCrossRef
16.
Huang KC, Lin RC, Kormas N, et al. Plasma leptin is associated with insulin resistance independent of age, body mass index, fat mass, lipids, and pubertal development in nondiabetic adolescents. Int J Obes Relat Metab Disord. 2004;28:470–5.PubMedCrossRef
17.
Herder C, Schneitler S, Rathmann W, et al. Low-grade inflammation, obesity and insulin resistance in adolescents. J Clin Endocrinol Metab. 2007;92:4569–74.PubMedCrossRef
18.
Chu NF, Wang DJ, Shieh SM, et al. Plasma leptin concentrations and obesity in relation to insulin resistance syndrome components among school children in Taiwan—The Taipei Children Heart Study. Int J Obes. 2000;24:1265–71.CrossRef
19.
Centers for Disease Control and Prevention. State-specific incidence of diabetes among adults-participating states, 1995–1997 and 2005–2007. MMWR Morb Mortal Wkly Rep. 2008;57:1169–73.
20.
National High Blood Pressure Education Program, Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114:555–76.CrossRef
21.
Ford ES, Ajani UA, Mokdad AH. The metabolic syndrome and concentrations of C-reactive protein among US youth. Diabetes Care. 2005;28:878–81.PubMedCrossRef
22.
Fernández JR, Redden DT, Pietrobelli A, et al. Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents. J Pediatr. 2004;145:439–44.PubMedCrossRef
23.
Keskin M, Kurtoglu S, Kendirci M, et al. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics. 2005;115:e500–3.PubMedCrossRef
24.
Okosun IS, Seale JP, Boltri JM, et al. Trends and clustering of cardiometabolic risk factors in American adolescents from 1999 to 2008. J Adolesc Health. 2012;50:132–9.PubMedCrossRef
25.
Venegas HL, Pérez CM, Suárez EL, et al. Prevalence of obesity and its association with blood pressure, serum lipids, and selected lifestyles in a Puerto Rican population of adolescents 12–16 years of age. P R Health Sci J. 2003;22(2):137–43.PubMed
26.
Stettler N, Elliot MR, Kallan MJ, et al. High prevalence of overweight among pediatric users of community health centers. Pediatrics. 2005;116(3):e381–8.PubMedCentralPubMedCrossRef
27.
Centers for Disease Control and Prevention. Obesity prevalence among low-income, preschool-aged children—United States, 1998–2008. MMWR Morb Mortal Wkly Rep. 2009;58:769–73.
28.
Rivera-Soto WT, Rodríguez-Figueroa L, Calderón G. Prevalence of childhood obesity in a representative sample of elementary school children in Puerto Rico by socio-demographic characteristics, 2008. P R Health Sci J. 2010;29:357–63.PubMed
29.
Garza JR, Acosta-Pérez E, Prelip M, et al. Occurrence and correlates of overweight and obesity among island Puerto Rican youth. Ethn Dis. 2011;21(2):163–9.PubMedCentralPubMed
30.
Vangipurapu J, Stančáková A, Kuulasmaa T, et al. Association between liver insulin resistance and cardiovascular risk factors. J Intern Med. 2012;272:402–8.PubMedCrossRef
31.
Bao W, Srinivasan SR, Wattigney WA, et al. Persistence of multiple cardiovascular risk clustering related to syndrome X from childhood to young adulthood. The Bogalusa Heart Study. Arch Intern Med. 1994;154:1842–7.PubMedCrossRef
32.
Huang KC, Chen CL, Chuang LM, et al. Plasma adiponectin levels and blood pressures in nondiabetic adolescent females. J Clin Endocrinol Metab. 2003;88:4130–4.PubMedCrossRef
33.
Rubin DA, McMurray RG, Hackney AC, et al. Relationship between cardiovascular risk factors and adipokines in adolescents. Horm Res Paediatr. 2011;76:123–9.PubMedCentralPubMedCrossRef
34.
Tschritter O, Fritsche A, Thamer C, et al. Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes. 2003;52:239–43.PubMedCrossRef
35.
Kim ES, Park JH, Lee MK, et al. Associations between fatness, fitness, IGF and IMT among obese Korean male adolescents. Diabetes Metab J. 2011;35:610–8.PubMedCentralPubMedCrossRef
36.
Sesti G, Sciacqua A, Cardellini M, et al. Plasma concentration of IGF-I is independently associated with insulin sensitivity in subjects with different degrees of glucose tolerance. Diabetes Care. 2005;28(1):120–5.PubMedCrossRef
37.
Theodorakis MJ, Carlson O, Muller DC, et al. Elevated plasma glucose-dependent insulinotropic polypeptide associates with hyperinsulinemia in impaired glucose tolerance. Diabetes Care. 2004;27:1692–8.PubMedCrossRef
38.
Beck-Nielsen H, Groop LC. Metabolic and genetic characterization of prediabetic states: sequence of events leading to non-insulin-dependent diabetes mellitus. J Clin Invest. 1994;94:1714–21.PubMedCentralPubMedCrossRef
39.
Enoki S, Mitsukawa T, Takemura J, et al. Plasma islet amyloid polypeptide levels in obesity, impaired glucose tolerance and non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract. 1992;15:97–102.PubMedCrossRef
40.
Asakawa A, Inui A, Yuzuriha H, et al. Characterization of the effects of pancreatic polypeptide in the regulation of energy balance. Gastroenterology. 2003;124:1325–36.PubMedCrossRef
Metadata
Title
High Prevalence of Cardiometabolic Risk Factors in Hispanic Adolescents: Correlations with Adipocytokines and Markers of Inflammation
Authors
Cynthia M. Pérez
Ana P. Ortiz
Enrique Fuentes-Mattei
Guermarie Velázquez-Torres
Damarys Santiago
Katya Giovannetti
Raúl Bernabe
Mong-Hong Lee
Sai-Ching J. Yeung
Publication date
01-10-2014
Publisher
Springer US
Published in
Journal of Immigrant and Minority Health / Issue 5/2014
Print ISSN: 1557-1912
Electronic ISSN: 1557-1920
DOI
https://doi.org/10.1007/s10903-013-9866-9

Other articles of this Issue 5/2014

Journal of Immigrant and Minority Health 5/2014 Go to the issue

Original Paper

The Impact of Parental Migration on the Mental Health of Children Left Behind

Erratum

Erratum to: Musculoskeletal Injury, Functional Disability, and Health-Related Quality of Life in Aging Mexican Immigrant Farmworkers

Original Paper

Social-Cognitive and Socio-Cultural Predictors of Hepatitis B Virus-Screening in Turkish Migrants, the Netherlands

Original Paper

Assessing Adherence to Accepted National Guidelines for Immigrant and Refugee Screening and Vaccines in an Urban Primary Care Practice: A Retrospective Chart Review

Original Paper

Strategies to Recruit Minority persons: A Systematic Review

Original Paper

Attitudes and Beliefs Regarding Cardiovascular Risk Factors Among Bangladeshi Immigrants in the US